登入選單
返回Google圖書搜尋
Diabetes Book-8, Selective SGLT2 Inhibitors- English
註釋

Diabetes is a metabolic disorder, where the body does not produce insulin or does not use it efficiently, resulting in high blood sugar.

High blood sugar further increases the risk of kidney failure, blindness, amputation of legs (due to loss of sensations), and even heart attack.

Today we have 13 groups of excellent diabetes medications, which can really keep us very healthy.

This book talks about the role of the medications group called “Selective Sodium-Glucose Transporter-2 (SGLT2) Inhibitors” in diabetes management, covering important facts about them.

It further talks about Farxiga – a new medicine to improve Blood Sugar Control.

It also throws light on the four medications that come under this group Canagliflozin, Dapagliflozin, Empagliflozin, and Ertugliflozin